News

Published on 19 Jan 2022 on Guru Focus

Andreas Halvorsen Reinforces G


Article preview image

The firm selects stocks based on its understanding of the company’s fundamentals, business model and management team, while also taking cyclical and...

NYSE.CRL price evolution
NASDAQ.GH price evolution
NASDAQ.PACB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
21 Countries that Have the Highest Rates of Cancer Deaths

In this article, we will be taking a look at the 21 countries that have the highest rates of canc...

Insider Monkey via Yahoo Finance 28 Feb 2024

Earnings call: Guardant Health sees 22% revenue growth in Q4 2023 By Investing.com

Guardant Health , Inc. (NASDAQ:GH), a leading precision oncology company, reported a 22% increase...

Investing.com 23 Feb 2024

Guardant Health Insiders Added US$5.05m Of Stock To Their Holdings

In the last year, multiple insiders have substantially increased their holdings of Guardant Healt...

Simply Wall St. via Yahoo Finance 23 Feb 2024

Earnings call: Guardant Health sees 22% revenue growth in Q4 2023 By Investing.com

Guardant Health , Inc. (NASDAQ:GH), a leading precision oncology company, reported a 22% increase...

Investing.com 23 Feb 2024

Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript

Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript February 22, 2024 Guardant Hea...

Insider Monkey via Yahoo Finance 23 Feb 2024

Guardant Health Inc (GH) Reports 25% Revenue Growth in Full Year 2023

Revenue Growth: Full year 2023 revenue increased by 25% to $563.9 million, driven by a 39% growth...

GuruFocus.com via Yahoo Finance 22 Feb 2024

Baillie Gifford Acquires New Stake in Guardant Health Inc

On December 1, 2023, Baillie Gifford (Trades, Portfolio), a renowned investment management firm, ...

GuruFocus.com via Yahoo Finance 31 Jan 2024

Guardant Health (NASDAQ:GH) shareholders have endured a 78% loss from investing in the stock three...

Guardant Health, Inc. (NASDAQ:GH) shareholders should be happy to see the share price up 13% in t...

Simply Wall St. via Yahoo Finance 28 Dec 2023

Guardant Health shares slide as colon cancer test is set for FDA advisory committee review

Shares of Guardant Health Inc. dropped 9.5% premarket on Wednesday after the company said late Tu...

Market Watch 20 Dec 2023

Blood-Based Colorectal Cancer CRC Screening Market Likely to Benefit From FDA's Panel Surprise...

Tuesday, Guardant Health Inc (NASDAQ: GH) announced that the FDA's Molecular and Clinical Genetic...

Benzinga via Yahoo Finance 20 Dec 2023